Related Experiment Video
Updated: Dec 22, 2025

10:35
Stereotactic Radiosurgery for Gynecologic Cancer
Published on: April 17, 2012
18.6K
Advances in cancer imaging require renewed radiotherapy dose and target volume concepts
Johannes H A M Kaanders1, Sven van den Bosch1, Tim Dijkema1
1Department of Radiation Oncology Radboudumc, Nijmegen, The Netherlands.
Summary
Modern imaging advances can improve cancer radiotherapy targeting. New concepts for radiotherapy dose prescription and target volume definition, using advanced imaging, can reduce treatment toxicity and enhance combination cancer therapies.
Area of Science:
- Oncology
- Radiotherapy
- Medical Imaging
Background:
- Diagnostic imaging has advanced, offering potential for enhanced cancer therapeutic targeting.
- Current conceptual frameworks for radiotherapy target volume definition and dose prescription lag behind imaging capabilities.
Purpose of the Study:
- To discuss how modern imaging can inform new concepts for radiotherapy dose prescription and target volume definition.
- To illustrate these concepts using head and neck cancer as an example.
- To explore the potential impact on reducing radiation-induced toxicity and combining radiotherapy with systemic therapies.
Main Methods:
- This is an opinion paper, presenting a conceptual discussion.
- It reviews the potential contributions of modern imaging technologies.
- Case examples, specifically head and neck cancer, are used for illustration.
Main Results:
- Modern imaging offers opportunities to redefine radiotherapy target volumes and dose prescription strategies.
- New approaches can potentially minimize radiation-associated toxicity.
- These advancements may significantly impact the integration of radiotherapy with systemic cancer treatments.
Conclusions:
- There is a need to align radiotherapy planning concepts with advancements in diagnostic imaging.
- Implementing novel imaging-guided strategies can lead to more precise and safer cancer treatments.
- The integration of advanced imaging holds promise for improving patient outcomes in combined-modality cancer therapy.
Related Concept Videos
Cancer Vaccines
870
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
870
Targeted Cancer Therapies
8.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.5K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Cancer Therapies
9.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.7K

